Atossa遺傳學 ATOS 深 滬
等待開盤 11-03 09:30:00 美东时间
0.8896
+0.010
+1.09%
華盛通- 最 高0.909
- 今 開0.873
- 成交量 44.45万股
- 最 低 0.87
- 昨 收 0.88
- 總市值 1.15亿
- 52周最高 1.66
- 市盈率 靜 --
- 換手率 0.34%
- 52周最低 0.5526
- 委 比 -88.70%
- 總股本 1.29亿
- 歷史最高 2232.00
- 量 比 0.76
- 振 幅 4.43%
- 歷史最低 0.50
- 每 手 1
- 風險率 0.19%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Netflix Announces Ten-For-One Stock Split
LOS GATOS, Calif., Oct. 30, 2025 /PRNewswire/ -- Netflix, Inc. (Nasdaq: NFLX) announced today that its Board of Directors has approved a ten-for-one forward stock split of the Company's comm...
10-31 04:10
AgEagle Aerial Systems Expands Partnership With Tough Stump Technologies To Launch New HELIOS Kit Platform For eBee VISION Drone
New Offering incorporates Advanced EagleNXT VISION Drone, Providing Advantage of Real-Time Video Feeds; Expanded Partnership Provides Greater Capability for OperatorsWASHINGTON D.C., Oct. 16, 2025 (GLOBE NEWSWIRE) --
10-16 20:03
Atossa Therapeutics Appoints New Chief Financial Officer
Atossa Therapeutics ( ($ATOS) ) has shared an update. On October 14, 2025, Atos...
10-14 20:22
Atossa Therapeutics Appoints Mark Daniel As CFO
25+ year life-sciences finance leader brings revenue-forecasting rigor, public-company controls, and capital-markets experience as Atossa prepares for commercial operations with (Z)-endoxifenSEATTLE, Oct. 14, 2025
10-14 20:15
Atossa Therapeutics Releases Updated Corporate Presentation
Atossa Therapeutics ( ($ATOS) ) has provided an announcement. On September 26, ...
09-27 05:27
美股大行评级 | 潜在涨幅1650.0%！Ascendiant Capital维持GRI Bio"买入"评级，目标价上调至35美元
今日重点评级关注：Ascendiant Capital：维持GRI Bio"买入"评级，目标价从34美元升至35美元；Ascendiant Capital：维持Atossa Therapeutics"买入"评级，目标价从7.5美元升至7.75美元
09-23 09:52
西方石油(OXY.US)直言“抓碳”面临融资压力：自愿市场难签长约+封存风险不对称
西方石油公司的高管称，直接空气捕集模式目前不具“银行可融资性”。自愿市场难签长约、封存风险不对称，DAC规模化可谓困难重重。
09-19 07:06
Atossa Therapeutics Appoints CORE IR for Investor Relations, Shareholder Communications and Public Relations Services
<p><p><em>增强投资者意识，加强股东互动，扩大目标受众</em></p> <p>Seattle, 2025年9月17日 ( Globe NewsWire ) -- Atossa Therapeutics, Inc. (纳斯达克代码: ATOS) 委托CORE IR 提供投资者关系和沟通服务。</p> <p> </p> <p> </p></p>
09-17 12:00
Netflix to Announce Third Quarter 2025 Financial Results
LOS GATOS, Calif., Sept. 15, 2025 /PRNewswire/ -- Netflix, Inc. (NASDAQ: NFLX) today announced it will post its third quarter 2025 financial results and business outlook on its investor rela...
09-16 00:00
Atossa Therapeutics Announces New Regulatory Strategy
Atossa Therapeutics ( ($ATOS) ) just unveiled an update. On September 8, 2025, ...
09-08 20:59
